Monoacylated Benzo Crown Ether Ion Channels for Membrane Stability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current synthetic ion channels based on benzo(crown-ethers face challenges in membrane stability and cytotoxicity, with many compounds causing membrane lysis and being highly cytotoxic, limiting their functional characterization and potential applications in biological systems.
Innovation Solution
Development of monoacylated benzo(crown-ether) (MAcBCE) and monoalkylated benzo(crown-ether) (MAkBCE) compounds that self-assemble into non-toxic, membrane-stable supramolecular ion channels, lacking hydrogen-bonding capabilities previously thought essential for channel activity, allowing for controlled ion transport and potential use in drug delivery systems.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional benzo(crown-ether) compounds are used to form ion channels, then ion transport activity is achieved, but membrane stability deteriorates and cytotoxicity increases
Solution Approach 1:
The patent modifies the chemical parameters of benzo(crown-ether) compounds by introducing specific substituents (fluorine atoms at positions 2 and 6, and chlorine atoms at positions 3 and 5) to alter the compound's interaction with membrane lipids. This parameter change reduces membrane lysis and cytotoxicity while preserving ion channel activity, resolving the contradiction between channel function and membrane stability.
Solution Approach 2:
The invention creates composite molecular structures by combining the benzo(crown-ether) core with specific halogen substituents (fluorine and chlorine). This composite approach produces a new class of compounds that exhibit both ion channel-forming capability and reduced harmful effects on membrane integrity, simultaneously achieving reliability and reducing harm.
2Stability of the object's composition
If crown ethers are designed with high hydrophobicity for membrane partitioning, then membrane insertion is improved, but dissolution in aqueous solutions deteriorates
Solution Approach 1:
The patent applies local quality modification by introducing polar halogen substituents (fluorine and chlorine) at specific positions on the benzo(crown-ether) ring. These localized polar groups enhance aqueous solubility without significantly compromising the overall hydrophobicity needed for membrane partitioning, thus resolving the contradiction between membrane insertion and aqueous dissolution.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The MAcBCE and MAkBCE compounds form robust ion channels with ion preference, demonstrating channel activity in both biological and synthetic lipid bilayers without causing membrane lysis, making them suitable for bio-compatible synthetic ion channels and drug delivery applications.
Implementation Method 1
monoacylated benzo(crown-ether) (MAcBCE) compounds, monoalkylated benzo(crown-ether) (MAkBCE) compounds, or a combination thereof, such that the MAcBCE compounds, the MAkBCE compounds, or a combination of the MAcBCE and MAkBCE compounds self-assemble to form the ion channel in the membrane
Implementation Method 2
Crown ethers are cyclic molecules with high affinity to cations
Data Source
AI summary
Self-assembling compounds for the formation of ion channels in biological membranes include monoacylated benzo(crown-ether) (MAcBCE) compounds and monoalkylated benzo(crown-ether) (MAkBCE) compounds. Methods of preparing the MAcBCE and MAkBCE compounds and methods of forming an ion channel in a biological membrane are also disclosed.